In the fight against diabetes, access to accurate and up-to-date information is essential for health professionals. In this context, Diabeta stands out as an innovative tool, providing comprehensive and current information from drug SmPCs, guidelines, and protocols about diabetes.
SAVE VALUABLE TIME FOR SPECIALISTS
Diabeta is not just a simple medical chatbot; it is a valuable ally for diabetes specialists. Its main feature is the ability to save valuable time in the process of documenting treatments. In a world where every second counts, this advantage becomes crucial for doctors and pharmacists involved in diabetes management.
DISCOVERY OF EXCIPIENTS
In addition to information about treatments, Diabeta offers a unique functionality: the ability to find out the excipients of medicines. Excipients are the inactive components of a drug, such as bulking agents, binders, or dyes. Although these substances may seem trivial, they can play a crucial role in the tolerability and effectiveness of treatment.
Knowledge of excipients can be particularly helpful for patients with sensitivities or allergies to certain substances or for those who want to avoid certain ingredients. Through Diabeta, specialists can discover in detail the composition of each drug and make informed decisions regarding the treatment of diabetes.
THE IMPACT OF DIABETA ON DIABETES MANAGEMENT
Integrating Diabeta into medical practice can have a significant impact on diabetes management. Quick access to up-to-date information and detailed composition of medicines can help personalize treatment and optimize outcomes for patients.
Diabeta was developed by a Romanian company, Apollo Technologies, specialized in creating professional applications based on artificial intelligence. The app is made available to doctors in professional medical communities run by People and Companies, with the support of partners Novo Nordisk, Boehringer Ingelheim and Medtronic.
